 During its golden times, it was the greatest Yugoslav pharmaceutical company which controlled over 65% of SFR Yugoslavia market share.In 1991, the company was bought by American ICN Pharmaceuticals, led by Serbian American businessman Milan Panić.Even during the 1990s Yugoslav Wars and massive debts of FR Yugoslavia toward the company, it kept operating positive.